US EditionBioNTech's Strategy Chief, Who Led Deals to Reshape Company, Will Leave in September
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
BioNTech's strategy chief, who led deals to reshape company, will leave in September
BioNTech's strategy chief Ryan Richardson is exiting the German company on Sept. 30 "to pursue new professional opportunities," the infectious disease and cancer drug developer said Thursday. His departure, described as ...
The Mainz-based biotech company BioNTech is having to restructure its executive board. Chief Strategy Officer Ryan Richardson is stepping down at the end of September. He was responsible for BioNTech's IPO and expansion strategy, among other things.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
